Trial intelligence / Profile preview

MICADO micafungin pharmacokinetics in obese and non-obese adults

NL-OMON43057Phase 4Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of micafungin in candidiasis and mycoses (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Population pharmacokinetic model of micafungin, Model validation by bootstrap and 1 more. Started Jan 2017; status: active, not recruiting.

02

Drugs

micafungin
03

Conditions

candidiasismycoses

Beyond the preview

Go deeper on NL-OMON43057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call